Warner Chilcott to Present at the 2012 UBS Global Life Sciences Conference

 | Source: Warner Chilcott Warner Chilcott

DUBLIN, Ireland, Sept. 12, 2012 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that Roger Boissonneault, President and Chief Executive Officer, and Paul Herendeen, Executive Vice President and Chief Financial Officer, are scheduled to present at the 2012 UBS Global Life Sciences Conference on Wednesday, September 19th at 10:00 a.m. EDT.

The presentation will be simultaneously webcast at http://ir.wcrx.com/events.cfm, with an archived replay of the webcast available shortly thereafter at http://ir.wcrx.com/events.cfm.

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, urology and dermatology segments of the pharmaceutical markets, primarily in North America. The Company is fully integrated with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-G



            








        

            

                

                    
Mot-clé

                            
                                PHARMACEUTICALS
                            
                            
                                WEBCAST
                            

                



        




    

        

        
Coordonnées

        


    
    

 
    



        

        
            GlobeNewswire